Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us ...
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Outcomes of younger patients with mantle cell lymphoma; M-protein assessment during maintenance therapy in multiple myeloma; in vivo CAR T-cell generation using lentiviral vectors
0:59
0:59
Play later
Play later
Lists
Like
Liked
0:59
In this week's episode we’ll discuss the outcomes of younger patients with mantle cell lymphoma experiencing late relapse; learn more about mass spectrometry-based assessment of M-protein in peripheral blood during maintenance therapy in multiple myeloma and discuss in vivo CAR T-cell generation in non-human primates using lentiviral vectors. Featu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet Therapy
32:22
32:22
Play later
Play later
Lists
Like
Liked
32:22
Did you know that choosing between triplet and quadruplet regimens can make a significant difference in achieving optimal disease outcomes? Credit available for this activity expires: 08/19/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001477?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Insights into PV and ET: treating the AYA population, defining goals when treating patients, & more
11:50
11:50
Play later
Play later
Lists
Like
Liked
11:50
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPNs) characterized by the overproduction of red blood cells and platelets, respectively, due to mutations in hematopoietic stem cells. In this podcast, experts Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL; Lucia Masarova, MD, The University of Te…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PKD and the Gift of Life, feat. Patient Advocate Valen Keefer
40:10
40:10
Play later
Play later
Lists
Like
Liked
40:10
In this episode of the podcast we speak to Valen Keefer, a professional speaker and patient advocate who was diagnosed with polycystic kidney disease (PKD) at age 10. Valen has faced a number of challenges in her journey, including a double organ transplant, and now inspires other PKD and chronic illness patients by sharing her story. Connect with …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Management of Metastatic Urothelial Bladder Cancer
30:45
30:45
Play later
Play later
Lists
Like
Liked
30:45
Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Chikungunya Virus Vaccine: A New Addition to the Travel Vaccine Armamentarium
31:22
31:22
Play later
Play later
Lists
Like
Liked
31:22
Do you know how to identify individuals at risk for chikungunya virus-related disease who may benefit from vaccination? Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001434?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Undercover Partners: HIV, Immune Activation, and Inflammation
27:04
27:04
Play later
Play later
Lists
Like
Liked
27:04
Find out how to assess inflammation in people living with HIV, and how it drives early aging and comorbidities. Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001461?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
Introduced by Associate Editor Dr. Thomas Ortel, this bonus episode discusses the Review Series on Factor XI, published in volume 143 issue 15 of Blood Journal. Dr. Ortel is joined by contributing authors Owen McCarty, PhD, Gili Kenet, MD, and David Gailani, MD. Review Series Articles: Introduction to a review series on factor XI Biology of factor …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
ROS1-Alterations and Molecular Testing in Advanced NSCLC
16:28
16:28
Play later
Play later
Lists
Like
Liked
16:28
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements in non-small-cell lung cancer tumor biology and its implications for molecular testing and treatment selection including: ROS1-gene fusions in advanced lung cancer ROS1 testing recommendations with DNA …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1:15:58
1:15:58
Play later
Play later
Lists
Like
Liked
1:15:58
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast cancer following the 2024 ASCO Annual Meeting, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
46:12
46:12
Play later
Play later
Lists
Like
Liked
46:12
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Protective role of neonatal CMV infection in B-ALL; GVHD targets organoid-forming bile duct stem cells; seven-year outcomes for venetoclax-ibrutinib therapy in MCL
16:56
16:56
Play later
Play later
Lists
Like
Liked
16:56
In this week's episode we'll learn how cytomegalovirus infection early in life depletes preleukemic cells in a mouse model of B-cell acute lymphoblastic leukemia. After that we'll discuss new research, where GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Conversely, a TGF-beta inhibitor protects these stem cells …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Key Takeaways From 2024 ASCO Breakthrough
14:26
14:26
Play later
Play later
Lists
Like
Liked
14:26
Dr. Lillian Siu and Dr. Melvin Chua discuss the new technologies and novel therapeutics that were featured at the 2024 ASCO Breakthrough meeting. TRANSCRIPT Dr. Lillian Siu: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Lillian Siu, a medical oncologist and director of the Phase 1 Trials Program at the Princess Margaret Cancer Center in…
…
continue reading
In this episode of the mibo show, Shanti Das speaks with actress Jenifer Lewis about her battle with bipolar disorder and depression. This episode took place on location in Chicago at the Black Women’s Expo. Lewis said she first sought out mental health help during the AIDS epidemic when she saw her best friend covered in lesions due to the disease…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:36
52:36
Play later
Play later
Lists
Like
Liked
52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
Play later
Play later
Lists
Like
Liked
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice. CME in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges
18:41
18:41
Play later
Play later
Lists
Like
Liked
18:41
This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Selecting Antiseizure Medications and Aiming for Seizure Freedom
38:05
38:05
Play later
Play later
Lists
Like
Liked
38:05
How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation
32:15
32:15
Play later
Play later
Lists
Like
Liked
32:15
Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
Play later
Play later
Lists
Like
Liked
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Iron, HFE haemochromatosis, and infections; bispecific antibodies improve CAR T-cell response; determinants of outcome in NPM1-mutated AML
23:31
23:31
Play later
Play later
Lists
Like
Liked
23:31
In this week's episode we'll learn about iron, HFE hemochromatosis, and infections. In this large, population-based study, both high and low levels of plasma iron and transferrin saturation were associated with increased risks of infection. Then, we'll discuss how bispecific antibodies improve CAR T-cell response in B-cell malignancies. In-vitro an…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
Dr. Shaalan Beg and Dr. Arturo Loaiza-Bonilla discuss the potential of artificial intelligence to assist with patient recruitment and clinical trial matching using real-world data and next-generation sequencing results. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, your guest host for the podcas…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Host: Saad Z. Usmani, MD, MBA, FACP Guest: Joshua Richter, MD Guest: Ashley Steinberger, APP Release date: 8/15/2024Expiration date: 8/15/2025Estimated time to complete: 1.0 hour This activity is not accredited for CME/CE credit. This episode of Myeloma Matters reviews the latest data on bispecific antibody therapy for relapsed/refractory multiple …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel Agents and Strategies in Lung Cancer
1:01:43
1:01:43
Play later
Play later
Lists
Like
Liked
1:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Play later
Play later
Lists
Like
Liked
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more
17:29
17:29
Play later
Play later
Lists
Like
Liked
17:29
In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Treatment Goals and Targeted Therapies in Myasthenia Gravis
31:03
31:03
Play later
Play later
Lists
Like
Liked
31:03
Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Play later
Play later
Lists
Like
Liked
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and s…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59:35
59:35
Play later
Play later
Lists
Like
Liked
59:35
Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Immune fitness and response to taclistamab in R/R multiple myeloma; BCR::ABL1 M244V mutation causes resistance to asciminib; HSCT and myocardial fibrosis in young patients with SCD
16:59
16:59
Play later
Play later
Lists
Like
Liked
16:59
In this week's episode we’ll discuss how immune fitness impacts response to teclistamab in relapsed/refractory multiple myeloma; learn more about a new mechanism of resistance to asciminib conferred by the BCR::ABL1 M244V mutation, and discuss the impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
DESTINY-Breast06 and A-BRAVE: Advances in Breast Cancer Research
15:12
15:12
Play later
Play later
Lists
Like
Liked
15:12
Dr. Allison Zibelli and Dr. Erika Hamilton discuss the results of the DESTINY-Breast06 trial in HR+, HER2-low and HER2-ultralow metastatic breast cancer and the A-BRAVE trial in early triple-negative breast cancer, the results of which were both presented at the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Allison Zibelli: Hello, I'm Dr. Allison Zibell…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
1:14:59
1:14:59
Play later
Play later
Lists
Like
Liked
1:14:59
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Christopher Chambers, MD Guest: Adam H. Buchanan, MS, MPH Since multi-cancer early detection (MCED) testing is a new technology, there’s been some discussion in the field about the impact it may have on patients, especially in terms of potential psychological harm like anxiety related to positive test…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
37:22
37:22
Play later
Play later
Lists
Like
Liked
37:22
How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_msc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs
11:58
11:58
Play later
Play later
Lists
Like
Liked
11:58
Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, and Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon. They discuss key updates in si…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
49:32
49:32
Play later
Play later
Lists
Like
Liked
49:32
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
53:35
53:35
Play later
Play later
Lists
Like
Liked
53:35
Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Johnny Gill & Kenan Thompson: Prostate Health
37:34
37:34
Play later
Play later
Lists
Like
Liked
37:34
In this episode of the mibo show, Shanti Das talks with Grammy-nominated, multi-platinum singer/songwriter/producer & philanthropist Johnny Gill and Actor/Comedian/Producer Kenan Thompson about awareness surrounding prostate health. We also speak with Dr. Stan Frencher Jr, an associate professor of Urology at UCLA and Chief of Urology at the Dr. Ma…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decitabine in older patients with AML; EPCR and sickle chronic kidney disease; lymphocyte depletion versus post-transplant cyclophosphamide for mismatched donor transplant for inborn errors of immunity ...
22:53
22:53
Play later
Play later
Lists
Like
Liked
22:53
In this week's episode we’ll discuss the safety and efficacy of decitabine in older patients with AML; learn how heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice, and discuss the outcomes of treatment with HLA-mismatched HSCT with TCRab/CD19 lymphocyte depletion or post-HSCT cyclophosph…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Risks and Benefits of Taking a Break From Cancer Treatment
18:47
18:47
Play later
Play later
Lists
Like
Liked
18:47
Dr. Shaalan Beg and Dr. Arjun Gupta discuss the rationale behind treatment breaks and assess the pros and cons based on feedback and data from patients with advanced-stage gastrointestinal cancers. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, an adjunct associate professor at UT Southwestern's S…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Resiliency, Feat. Multiple Myeloma Patient Advocate Keisha Hickson
50:02
50:02
Play later
Play later
Lists
Like
Liked
50:02
In this episode of the podcast, we speak to professional speaker and community advocate Keisha Hickson, who was diagnosed with multiple myeloma in 2016. That’s a rare form of cancer that develops in a type of white blood cell called a plasma cell. We discuss navigating a rare cancer diagnosis, adjusting to a new normal and the importance of resilie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care
38:15
38:15
Play later
Play later
Lists
Like
Liked
38:15
Learn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
1:00:53
1:00:53
Play later
Play later
Lists
Like
Liked
1:00:53
Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 data sets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Optimizing the Identification of HER2-Low Breast Cancer
23:48
23:48
Play later
Play later
Lists
Like
Liked
23:48
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
Host: Jody Takemoto, PhD Guest: David Braun Identifying biomarkers for renal cell carcinoma (RCC) is critical since they can help direct our therapeutic approach, which is why several techniques that may be able to uncover new biomarkers are currently being investigated. Joining Dr. Jody Takemoto to review those techniques and their potential impac…
…
continue reading